EPO Patents = 2

Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Jing-Ping Liou (5 out of 23 patents)

Yun Yen (5 out of 23 patents)

Shiow-Lin Pan (3 out of 19 patents)

4. Chien Huang Lin (2 out of 3 patents)

5 patents: Sort by Forward Citations

1. 12453708 - Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases (2025-10-28),

2. 11919858 - Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases (2024-03-05),

3. 11833122 - Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases (2023-12-05),

4. 11084786 - Compounds and pharmaceutical composition associated with ubiquitination-proteasome system (2021-08-10),

5. 10745350 - Compounds and pharmaceutical composition associated with ubiquitination-proteasome system (2020-08-18),

Calgent Biotechnology Co., Ltd. is a global biotechnology company dedicated to developing innovative solutions for improving human health. With a focus on advanced research and development, Calgent Biotechnology strives to create cutting-edge technologies and products in the fields of genomics, molecular biology, and personalized medicine. Committed to excellence, Calgent Biotechnology is a leader in the biotechnology industry, driving advancements in healthcare and making a positive impact on society.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#787 in Taipei

#2,276 in Taiwan

Taipei, Taiwan

Calgent Biotechnology Co., Ltd.

Forward Citations = 0

4 inventors:

Jing-Ping Liou (5 out of 23 patents)

Yun Yen (5 out of 23 patents)

Shiow-Lin Pan (3 out of 19 patents)

4. Chien Huang Lin (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com